PubRank

Manuel Jurado

Author PubWeight™ 12.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. N Engl J Med 2016 2.36
2 Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009 1.23
3 Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum Immunol 2006 1.06
4 Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett 2007 1.06
5 Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One 2012 1.00
6 Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC maintenance: toward an implementation of microbiological quality assurance program in stem cell banks. Cloning Stem Cells 2008 0.87
7 Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer 2014 0.82
8 Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. Br J Haematol 2012 0.78
9 Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. Br J Haematol 2012 0.78
10 Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics. Swiss Med Wkly 2005 0.77
11 Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int J Oncol 2011 0.77
12 Negative feedback self-regulation contributes to robust and high-fidelity transmembrane signal transduction. J R Soc Interface 2013 0.77
13 Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. Cancer Epidemiol Biomarkers Prev 2014 0.77
14 Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. J Hum Genet 2013 0.76
15 Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles. Rev Esp Quimioter 2013 0.75